Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-491



Status:Recruiting
Conditions:Cardiology, Cardiology, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - 80
Updated:3/8/2019
Start Date:February 6, 2018
End Date:December 2019
Contact:MyoKardia Medical Affairs
Email:medinfo@myokardia.com
Phone:650-741-0900

Use our guide to learn which trials are right for you!

Randomized, Double-blind, Placebo-controlled, Two-Part, Adaptive Design Study of Safety, Tolerability, Preliminary Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Oral Doses of MYK-491 in Patients With Stable Heart Failure With Reduced Ejection Fraction

The purpose of this Phase 1b/2a study is to evaluate the safety, tolerability,
pharmacokinetics, and pharmacodynamics of MYK-491 in patients with DCM and stable heart
failure.


Key Inclusion Criteria:

- Has stable chronic heart failure with reduced ejection fraction

- Has adequate acoustic windows for echocardiography

Key Exclusion Criteria:

- Any significant structural cardiac abnormalities on Screening TTE

- At Screening, symptomatic hypotension or hypertension or bradycardia.

- Routinely scheduled outpatient intravenous (IV) infusions for heart failure (e.g.,
inotropes, vasodilators [e.g., nesiritide], diuretics) or routinely scheduled
ultrafiltration.

- Presence of protocol specified laboratory abnormalities at Screening.
We found this trial at
7
sites
Columbus, Ohio 43210
Principal Investigator: Ray Hershberger
1959
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
4085 University Blvd S # 1
Jacksonville, Florida 32216
Principal Investigator: Michael Koren
Phone: 904-732-9255
2134
mi
from 91732
Jacksonville, FL
Click here to add this to my saved trials
3181 Southwest Sam Jackson Park Road
Portland, Oregon 97239
503 494-8311
Principal Investigator: Samuel Camacho
Oregon Health and Science University In 1887, the inaugural class of the University of Oregon...
827
mi
from 91732
Portland, OR
Click here to add this to my saved trials
2301 Erwin Rd
Durham, North Carolina 27710
919-684-8111
Principal Investigator: Ravi Karra
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
2203
mi
from 91732
Durham, NC
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19104
Principal Investigator: Anjali Owens
?
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Saint Paul, Minnesota 55102
Principal Investigator: Les Forgosh
?
mi
from 91732
Saint Paul, MN
Click here to add this to my saved trials
Tullahoma, Tennessee 37388
Principal Investigator: Dinesh Gupta
1800
mi
from 91732
Tullahoma, TN
Click here to add this to my saved trials